S&P Futures
4,146.25 -0.50 (-0.01%) Dow Futures
32,765.00 +8.00 (+0.02%) Nasdaq Futures
13,237.75 +9.00 (+0.07%) Russell 2000 Futures
1,922.00 +0.20 (+0.01%) Crude Oil
89.25 +0.24 (+0.27%) Gold
1,788.30 -2.90 (-0.16%)
Ekso Bionics Holdings, Inc. (EKSO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.9000 |
| Open | 1.9500 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1000 |
| Day's Range | 1.9400 - 2.0797 |
| 52 Week Range | 1.5350 - 5.4100 |
| Volume | |
| Avg. Volume | 593,529 |
| Market Cap | 25.454M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0110 |
| Earnings Date | Apr 27, 2022 - May 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Ekso Bionics Reports Second Quarter 2022 Results
RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2022. Recent Highlights and Accomplishments Reported revenue of $3.5 million in the second quarter of 2022, an increase of 57% year-over-yearReceived 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market EksoNR for use w
- GlobeNewswire
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2022 after the close of trading on Thursday, July 28, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. A live webcas
